Home
Travere Therapeutics TVTX spent $160K on lobbying in Q2 2023 · Copyright, Taxation and 4 more issues
Trade details
- Type
- Lobbying report
- Amount
- $160,000
- Quarter
- Q2 2023
- Client
- Travere Therapeutics
- Reported
- 23/07/19
Down 11.1% from last quarter
What else happened in Travere Therapeutics around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Travere Therapeutics's other lobbying reports
- Travere Therapeutics
LobbyingTravere Therapeutics
LobbyingTravere Therapeutics
TVTX
$16K
$16K
Reported 08/04
for Q2
- Travere Therapeutics
LobbyingTravere Therapeutics
LobbyingTravere Therapeutics
TVTX
$70K
$70K
Reported 07/20
for Q2
- Travere Therapeutics
LobbyingTravere Therapeutics
LobbyingTravere Therapeutics
TVTX
$140K
$140K
Reported 07/20
for Q2
- Travere Therapeutics
LobbyingTravere Therapeutics
LobbyingTravere Therapeutics
TVTX
$16K
$16K
Reported 05/19
for Q1
- Travere Therapeutics
LobbyingTravere Therapeutics
LobbyingTravere Therapeutics
TVTX
$80K
$80K
Reported 04/20
for Q1